Inter‐organ communication: a gatekeeper for metabolic health DOI Creative Commons
Judit Castillo‐Armengol, Lluís Fajas, Isabel C. López‐Mejía

et al.

EMBO Reports, Journal Year: 2019, Volume and Issue: 20(9)

Published: Aug. 19, 2019

Review19 August 2019Open Access Inter-organ communication: a gatekeeper for metabolic health Judit Castillo-Armengol Center Integrative Genomics, University of Lausanne, Switzerland Search more papers by this author Lluis Fajas Corresponding Author [email protected] orcid.org/0000-0002-1283-9503 Isabel C Lopez-Mejia Information Castillo-Armengol1, *,1 and 1Center *Corresponding author. Tel: +41 21 692 41 11; E-mail: 4146; EMBO Reports (2019)20:e47903https://doi.org/10.15252/embr.201947903 See the Glossary abbreviations used in article. PDFDownload PDF article text main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Abstract Multidirectional interactions between organs periphery central nervous system have evolved concomitantly with multicellular organisms maintain whole-body energy homeostasis ensure organism's adaptation external cues. These are altered pathological conditions such as obesity type 2 diabetes. Bioactive peptides proteins, hormones cytokines, produced both peripheral system, key messengers inter-organ communication. Despite early discovery first than 100 years ago, recent studies taking advantage novel technologies shed light on multiple ways cells body communicate balance. This review briefly summarizes well-established concepts focuses advances describing how specific proteins mediate crosstalk gut, brain, other order homeostasis. Additionally, outlines improved knowledge about these networks is helping us redefine therapeutic strategies an effort promote healthy living fight disorders diseases. ACC Acetyl-CoA Carboxylase ADBR3 β3-adrenergic receptor AdipoR1/2 Adiponectin receptors AgRP Agouti-related peptide AKT Protein kinase B (PKB), also known AMPK AMP-activated protein kinase. Anorexigenic Hormone(s) or compound(s) resulting decreased appetite. ARC Arcuate nucleus ATP Adenosine trisphosphate Autocrine signaling method which cell releases molecule that will bind exert its action same cell. BAs Bile acids BAT Brown adipose tissue BMP8b Bone morphogenetic 8b cAMP Cyclic adenosine monophosphate CCK Cholecystokinin CNS Central CSF Cerebrospinal fluid CTSB Cathepsin CX43 Connexin 43 CXCL14 C-X-C motif chemokine ligand-14 Cytokines class small can be broad variety act molecules. In circulation, cytokines usually found smaller concentration hormones. DIO2 Type iodothyronine deiodinase DIO Diet-induced DMH Dorsomedial hypothalamus Endocrine released into bloodstream before binding exerting distant cells. Exosomes extracellular vesicles from constitute intercellular communication transmission macromolecules may contain cargo molecules like lipids, DNA, mRNAs miRNAs. FBN1 Profibrillin gene. precursor asprosin. FGF19 Fibroblast growth factor 19 FGF21 FNDC5 Fibronectin III domain-containing 5. irisin. FoxO1 Forkhead box O1 GH Growth hormone GHSR secretagogue GIP Glucose-dependent insulinotropic GLP-1 Glucagon-like 1 GLP-1R GLUT2 Glucose transporter HFD High-fat diet Hormones secreted given trigger integrative responses stimuli. IL-1Ra Interleukin antagonist IL-6 Interleukine 6 IRS-2 Insulin substrate JAK2 Janus Lcn5 Lipocalin 5 LEAP2 Liver-expressed antimicrobial LepRb Leptin b LHA Lateral hypothalamic area MAPK Mitogen-activating MCP1 Monocyte chemotactic Metrnl Meteorin-like mTOR Mammalian target rapamycin NE Norepinephrine NPY Neuropeptide Y Orexigenic increased Paracrine nearby PGC1α Peroxisome proliferator-activated gamma coactivator 1-α PKA A PM20D1 Peptidase M20 POA Preoptic POMC Pro-opiomelanocortin PSNS Parasympathetic system—The part autonomic involved regulation numerous basic functions. It stimulates “feed breed” “rest digest” functions antagonistic SNS. RBP4 Retinol 4 RPA Raphe pallidus SctR Secretin SNS Sympathetic “fight flight” responses. rapid urgent reactions PSNS. STAT3 Signal transducer activator transcription 3 T2D diabetes T3, T4 Thyroid TCPTP T-cell tyrosine phosphatase TGFβ Transforming β TGR5 BA TG Triglycerides TNF-α Tumor necrosis factor-α TSH Thyroid-stimulating UCP1 Uncoupling VAN Vagal afferent neurons VMH Ventromedial WAT White Introduction adapt conditions, different tissues each via signals. Peripheral produce plethora bioactive molecules, including (from Greek horme means impulsion), autocrine, paracrine, endocrine manner (see Glossary). immune namely 1, participate Alternatively, coordinates metabolism not only production neurohormones locally, but direct innervation 2-5. Indeed, sympathetic parasympathetic fibers innervating express enzymes crucial biosynthesis transport (neurotransmitters neuropeptides) necessary tissue-specific response Early research 19th century, most notably Claude Bernard, suggested involving chemical ensures 6. The term “hormone” was 1905 British physiologist Ernest Stalling describe gut secretin, described just prior 7, 8. Carl Ferdinand Cori Gerty then cycle lactate anaerobic glycolysis muscles recycled liver converted glucose. turn, glucose returned muscle where it metabolized 9. “Cori cycle” one examples efficient organs, facilitate demands. Key hormones, pancreatic insulin glucagon, were successfully identified, synthesized, therapy course 20th century. identification has exponentially years, giving rise terms hepatokines 10, myokines 11, adipokines 12, batokines 13, liver, muscle, white (WAT), brown (BAT), respectively. secretion varies according status body. They respond instance fasting feeding cycles 14, circadian rhythm 15, cold exposure 16, exercise17, thus participating adaptive ensuring flexibility. pathologic example, related dysfunction, obesity. As such, alterations currently contribute spectrum obesity-associated pathologies. Therefore, pharmacological interventions modify hormones/cytokines, directly delivering recombinant being explored promising approaches treat wide obesity-related review, we summarize mechanisms focus highlighted importance WAT, BAT, pancreas, maintenance fitness. role been recently discussed elsewhere 18 review. further concludes citing additional actors mediators states our opinion future directions field. control fasting/feeding section, discuss organismal consumption food (Fig 1), followed compensatory engaged low state 2). Figure 1. under conditionsFood ingestion several GLP-1, secretin LEAP2. signal brain reduce intake. intestine reduces bile acid (BA) synthesis. stimulate (and glucagon) pancreas. glycogen uptake decrease increase lipogenesis circulating triglycerides (TGs) WAT. Leptin, adipocytes, repress Moreover, lipolysis liver. Download figure PowerPoint 2. conditionsGhrelin conditions. targets Pancreatic glucagon ghrelin, blood levels. Glucagon hepatic gluconeogenesis glycogenolysis, well lipolysis. Ghrelin adiposity increasing lipid synthesis reducing fatty (FA) oxidation. Fasting asprosin adiponectin through expenditure Asprosin gluconeogenesis, whereas increases FA Increased levels physiological meal initiates triggered presence nutrients. Enteroendocrine sense nutrients intestinal lumen cholecystokinin (CCK), incretins; glucose-dependent (GIP); glucagon-like (GLP-1) 19, 20. Gut play their acting circulation activating paracrine manner. major gut-derived vagal (VANs) 21. Endogenous acts VANs inhibit actions modulated fact (GLP-1R) internalized upon translocate plasma membrane after when ghrelin low. work synergistically potentiate glucose-stimulated β-cells inhibits α-cells. exocrine pancreas activity proper environment digestion absorption intake activation (SctR) sensory nerves melanocortin 22, 23. After postprandial initiated changes nutrients, mainly (TG), engage system. An sensed GLUT2. sensing leads β-cell ultimately 24. parallel, release α-cells 25, 26. insulin-sensitive induce utilization storage preventing hyperglycemia. By regulates behavior modifies tissues, cognitive 27-31. promotes metabolization hexokinases de novo lipogenesis, while decreasing production. Intact is, however, dispensable repression absence 32, 33, highlighting 34. triggers promoting externalization GLUT4 expression specifically glucose-derived glycerol serves building blocks TGs; TGs serve fuel stock scarcity. avoid excessive intake, adiposity, unnecessary storage, deleterious effects organism, capability hormone-producing organ. adipocytes proportionally stores 35-37. widely highly expresses long form leptin (LepRb). signals constant stock. suppresses adrenal corticosteroids 38, 39. activate oxidation AMPK-dependent 40. Whether process indirect remains unclear 41. (BAs) (Fgf15 mice) ileum. induces feedback 42. repressing 43, 44, independently insulin. Importantly, Fgf15 modulate 45 46. More recently, liver-expressed (LEAP2), initially liver-produced peptide, peptide. fed state, suppressed fasting. reported endogenous receptor, (GHSR). fully blunt (GH) 47. study adds growing list connect control. Thus far, body, state. Upon meal, aforementioned orchestrate coordinated substrates, initiating negative loop satiety “positive balance” 1). When low, lack stomach, glucose, replenish alternative substrates keep functioning. gastric epithelium stomach empty. Plasma concentrations high during 48. potent inducer 49, now GHSR. exerts orexigenic centrally arcuate (ARC) triggering agouti-related (AgRP) neuropeptide (NPY) However, exact mechanism plays unclear. To date, three hypotheses follows: (i) VANs, (ii) synthesized locally feeding, (iii) crosses blood–brain barrier activates 50. attenuates intracellular localization counteracting 51. secretion, carbohydrate use, stimulating synthesis, 50, 52. shown require intact 53. Adipokine modified rapidly reduction switch “fasted state” “fed 54. contrast leptin, at least cerebrospinal (CSF) 55, 56. Overall, inversely proportional correlate Numerous (adiponectin essentially ubiquitous). ARC, expenditure, suggesting anorexigenic sensitivity independent mechanisms: phosphorylation, AMPK-independent involves ceramide 57, IL-6-dependent upregulation (IRS-2) 58. 39 remain debated Asprosin, fasting-induced adipokine production, identified 59. C-terminal cleavage product profibrillin (FBN1 gene). encoded last two exons mice. release, without catecholamines, glucocorticoids. β-adrenergic (CNS) 60. (FGF21) hepatokine 61 62, 63. turn lipolysis, ketogenesis, availability brain. worth noting knockout mice exhibit lower glycemia fasted ketone bodies 64, 65. Fasting-induced hypoglycemia results stimulated glucagon. Hypoglycemia GLUT2-positive input 66. pathway mobilization (glycogenolysis) and, if prolonged, (gluconeogenesis), glycogenesis. preserve free glycerol. Glycerol transported oxidized gluconeogenesis. Albumin-bound tissues. promoted (SNS) innervation. norepinephrine (NE) similar tone could 67, 68. Notably, depots sparser 69. denser regions subcutaneous (or inguinal) 70, 71. cell-to-cell connexin (CX43) containing gap junctions essential disseminating adrenergic 72. situations deprivation counter regulatory maintains enough prevent function, energy-providing available all organs. accompanied overall energy. non-shivering thermogenesis temperature, developed homeotherms. Mammals specialized heat 73. especially abundant hibernating mammals 74, adult humans 75. stress summarized Fig 3. exposureCold stimuli, skin, thermoregulatory secrete orexin BMP8B thermogenesis. responsible local BAT. hypothalamic–pituitary–thyroid axis activated thyroid (T3 T4) Cold shivering myokine Irisin If sustained over time, undergoes browning process. addition, cold-dependent Finally, WAT; Cold-induced organ integrates CNS. terminals processed preoptic (POA), center 76. transduction regions, lateral (LHA), ventromedial (VMH), dorsomedial (DMH), (ARC). Orexin producing located LHA, named neurons, administration therefore 77. infusion firing 78. Both interact Hypothalamic bone (BMP8b) enhances projections 79. Interestingly, 80. Several linked cold. For stimulation thermogenic rats 81. Similarly, incretin 82. Outflow areas premotor stem region raphe (RPA). broadly present within parenchyma 83. hydroxylase, enzyme catecholamine 84. catecholamine-responsive tissue. constituted droplets number mitochondria. (ADBR3) cAMP/PKA pathway, uncoupling (UCP1). Free acids, activators uncouple mitochondrial respiration 73, 85. Apart 86. T3 synthetized gland pituitary thyroid-stimulating (TSH) 87. access transporters. active (DIO2) compensating gland-secreted 88.

Language: Английский

Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism DOI Creative Commons
Xiaojiao Zheng, Tianlu Chen, Runqiu Jiang

et al.

Cell Metabolism, Journal Year: 2020, Volume and Issue: 33(4), P. 791 - 803.e7

Published: Dec. 18, 2020

Language: Английский

Citations

296

Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity DOI Open Access
Alana O’Mara, James W. Johnson,

Joyce D. Linderman

et al.

Journal of Clinical Investigation, Journal Year: 2020, Volume and Issue: 130(5), P. 2209 - 2219

Published: Jan. 21, 2020

BACKGROUNDMirabegron is a β3-adrenergic receptor (β3-AR) agonist approved only for the treatment of overactive bladder. Encouraging preclinical results suggest that β3-AR agonists could also improve obesity-related metabolic disease by increasing brown adipose tissue (BAT) thermogenesis, white (WAT) lipolysis, and insulin sensitivity.METHODSWe treated 14 healthy women diverse ethnicities (27.5 ± 1.1 years age, BMI 25.4 1.2 kg/m2) with 100 mg mirabegron (Myrbetriq extended-release tablet, Astellas Pharma) 4 weeks in an open-label study. The primary endpoint was change BAT activity as measured [18F]-2-fluoro-d-2-deoxy-d-glucose (18F-FDG) PET/CT. Secondary endpoints included resting energy expenditure (REE), plasma metabolites, glucose metabolism assessed frequently sampled intravenous tolerance test.RESULTSChronic therapy increased activity. Whole-body REE higher, without changes body weight or composition. Additionally, there were elevations levels beneficial lipoprotein biomarkers HDL ApoA1, well total bile acids. Adiponectin, WAT-derived hormone has antidiabetic antiinflammatory capabilities, acute 35% higher upon completion Finally, test revealed sensitivity, effectiveness, secretion.CONCLUSIONThese findings indicate human can be after chronic pharmacological stimulation support investigation disease.TRIAL REGISTRATIONClinicaltrials.gov NCT03049462.FUNDINGThis work supported grants from Intramural Research Program NIDDK, NIH (DK075112, DK075116, DK071013, DK071014).

Language: Английский

Citations

292

Reassessing Human Adipose Tissue DOI
Aaron M. Cypess

New England Journal of Medicine, Journal Year: 2022, Volume and Issue: 386(8), P. 768 - 779

Published: Feb. 23, 2022

Adipose tissue can more than double in mass and then return to baseline. This review discusses the functional roles of human white brown adipose its excess obesity, as well far-reaching, complementary physiological endocrine system.

Language: Английский

Citations

286

Targeting the alternative bile acid synthetic pathway for metabolic diseases DOI Creative Commons
Jia Wang, Meilin Wei,

Cynthia Rajani

et al.

Protein & Cell, Journal Year: 2020, Volume and Issue: 12(5), P. 411 - 425

Published: Nov. 30, 2020

Abstract The gut microbiota is profoundly involved in glucose and lipid metabolism, part by regulating bile acid (BA) metabolism affecting multiple BA-receptor signaling pathways. BAs are synthesized the liver multi-step reactions catalyzed via two distinct routes, classical pathway (producing 12α-hydroxylated primary BA, cholic acid), alternative non-12α-hydroxylated chenodeoxycholic acid). BA synthesis excretion a major of cholesterol catabolism, thus, implicated variety metabolic diseases including obesity, insulin resistance, nonalcoholic fatty disease. Additionally, both oxysterols function as molecules that activate nuclear membrane receptor-mediated pathways various tissues, glucose, homeostasis, inflammation, energy expenditure. Modulating composition to regulate an interesting novel direction for developing therapies In this review, we summarize most recent findings on role synthetic pathways, with focus pathway, which has been under-investigated, treating hyperglycemia We also discuss future perspectives develop promising pharmacological strategies targeting treatment diseases.

Language: Английский

Citations

234

The Effects of Temperature on Animal Gut Microbiomes DOI Creative Commons
Juan Pedro Sepúlveda-Rojas, Andrew H. Moeller

Frontiers in Microbiology, Journal Year: 2020, Volume and Issue: 11

Published: March 10, 2020

Temperature is a prominent abiotic environmental variable that drives the adaptive trajectories of animal lineages and structures composition communities. Global temperature regimes are expected to undergo rapid shifts in next century, yet for many taxa we lack an understanding consequences these predicted populations. In this review, synthesize recent evidence variation shapes function gut microbiomes, key regulators host physiology, with potential population responses climate change. Several studies spanning range taxa, including Chordata, Arthropoda, Mollusca, have reported repeatable associations between community microbiome. several cases, same microbiome been observed across distantly related suggesting existence conserved mechanisms underlying temperature-induced plasticity. Extreme temperatures can disrupt stability alpha-diversity within microbiomes individual hosts generate beta-diversity among Microbiome states resulting from extreme associated, some cases causally linked, both beneficial deleterious effects on phenotypes. We propose routes by which changes may impact fitness, colonization resistance gut, energy nutrient assimilation, life history traits. Cumulatively, available data indicate disruption be mechanism changing will fitness wild-living

Language: Английский

Citations

222

TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue DOI Creative Commons
Laura A. Velázquez‐Villegas,

Alessia Perino,

Vera Lemos

et al.

Nature Communications, Journal Year: 2018, Volume and Issue: 9(1)

Published: Jan. 10, 2018

Remodelling of energy storing white fat into expending beige could be a promising strategy to reduce adiposity. Here, we show that the bile acid-responsive membrane receptor TGR5 mediates beiging subcutaneous adipose tissue (scWAT) under multiple environmental cues including cold exposure and prolonged high-fat diet feeding. Moreover, administration TGR5-selective acid mimetics thermoneutral housed mice leads appearance adipocyte markers increases mitochondrial content in scWAT Tgr5 +/+ but not their -/- littermates. This phenotype is recapitulated vitro differentiated adipocytes, which activation free fatty availability through lipolysis, hence fuelling β-oxidation thermogenic activity. signalling also induces fission ERK/DRP1 pathway, further improving respiration. Taken together, these data identify as druggable target promote with potential applications management metabolic disorders.

Language: Английский

Citations

211

Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis DOI Creative Commons
John Y.L. Chiang, Jessica M. Ferrell

Liver Research, Journal Year: 2020, Volume and Issue: 4(2), P. 47 - 63

Published: June 1, 2020

Cholesterol 7 alpha-hydroxylase (CYP7A1, EC1.14) is the first and rate-limiting enzyme in classic bile acid synthesis pathway. Much progress has been made understanding transcriptional regulation of CYP7A1 gene expression underlying molecular mechanisms feedback last three decades. Discovery acid-activated receptors their roles lipid, glucose energy metabolism have translated to development acid-based drug therapies for treatment liver-related metabolic diseases such as alcoholic non-alcoholic fatty liver diseases, cirrhosis, diabetes, obesity hepatocellular carcinoma. This review will provide an update on advances our biology mechanistic insights 40 years.

Language: Английский

Citations

190

A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility DOI Creative Commons
Meilin Wei, Fengjie Huang, Ling Zhao

et al.

EBioMedicine, Journal Year: 2020, Volume and Issue: 55, P. 102766 - 102766

Published: May 1, 2020

BackgroundThe composition of the bile acid (BA) pool is closely associated with obesity and modified by gut microbiota. Perturbations microbiota shape BA composition, which, in turn, may alter important signaling affect host metabolism.MethodsWe investigated high BMI subjects from a human cohort study fat diet (HFD) prone (HF-OP) / HFD resistant (HF-OR) mice model. Gut was analysed metagenomics sequencing. GLP-1 secretion gene regulation studies involved ELISA, qPCR, Western blot, Immunohistochemistry, Immunofluorescence staining.FindingsWe found that proportion non-12-OH BAs significantly decreased unhealthy subjects. The HF-OR had an enhanced level BAs. Non-12-OH including ursodeoxycholate (UDCA), chenodeoxycholate (CDCA), lithocholate (LCA) were HF-OP altered Clostridium scindens positive correlation UDCA LCA. Gavage increased levels hepatic BAs, accompanied elevated serum 7α-hydroxy-4-cholesten-3-one (C4) levels. In mice, downregulated expression ileum PGC1α, UCP1 brown adipose tissue. addition, we identified attenuated diet-induced via enhancing BAs.InterpretationOur highlights dysregulated mediated contributes to susceptibility, suggesting modulation could be promising strategy for therapy.

Language: Английский

Citations

188

Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters DOI Creative Commons
Lulu Sun,

Yuanyuan Pang,

Xuemei Wang

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2019, Volume and Issue: 9(4), P. 702 - 710

Published: Feb. 16, 2019

Since metabolic process differs between humans and mice, studies were performed in hamsters, which are generally considered to be a more appropriate animal model for of obesity-related disorders. The modulation gut microbiota, bile acids the farnesoid X receptor (FXR) axis is correlated with obesity-induced insulin resistance hepatic steatosis mice. However, interactions among FXR disorders remained largely unexplored hamsters. In current study, hamsters fed 60% high-fat diet (HFD) administered vehicle or an antibiotic cocktail by gavage twice week four weeks. Antibiotic treatment alleviated HFD-induced glucose intolerance, inflammation accompanied decreased lipogenesis elevated thermogenesis subcutaneous white adipose tissue (sWAT). livers antibiotic-treated cytochrome P450 family 7 subfamily B member 1 (CYP7B1) alternative acid synthesis pathway was upregulated, contributing hydrophilic profile increased tauro-β-muricholic (TβMCA). intestinal signaling suppressed but unchanged liver. This study potential translational significance determining role microbiota-mediated metabolism modulating diet-induced intolerance hamster.

Language: Английский

Citations

171

Metabolic Messengers: bile acids DOI
Alessia Perino, Kristina Schoonjans

Nature Metabolism, Journal Year: 2022, Volume and Issue: 4(4), P. 416 - 423

Published: March 25, 2022

Language: Английский

Citations

127